Genomics BioSci & Tech. Co.Ltd.
Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan.
Genomics BioSci & Tech. Co.Ltd. (4195) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.029x
Based on the latest financial reports, Genomics BioSci & Tech. Co.Ltd. (4195) has a cash flow conversion efficiency ratio of -0.029x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-22.95 Million) by net assets (NT$799.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genomics BioSci & Tech. Co.Ltd. - Cash Flow Conversion Efficiency Trend (2019–2023)
This chart illustrates how Genomics BioSci & Tech. Co.Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Genomics BioSci & Tech. Co.Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genomics BioSci & Tech. Co.Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EBQLF
PINK:EBQLF
|
N/A |
|
C3 Metals Inc
OTCQB:CUAUF
|
-0.012x |
|
Halmont Properties Corporation
V:HMT
|
0.002x |
|
Grupo Concesionario del Oeste SA
BA:OEST
|
0.033x |
|
Sai Gon Mien Trung Beer JSC
VN:SMB
|
N/A |
|
Medical Developments International Limited
PINK:MDDVF
|
0.013x |
|
Atrium Real Estate Investment Trust
KLSE:5130
|
0.125x |
|
Ideal Bike
TWO:8933
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Genomics BioSci & Tech. Co.Ltd. (2019–2023)
The table below shows the annual cash flow conversion efficiency of Genomics BioSci & Tech. Co.Ltd. from 2019 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | NT$765.51 Million | NT$-96.02 Million | -0.125x | -368.49% |
| 2022-12-31 | NT$789.13 Million | NT$-21.13 Million | -0.027x | +34.48% |
| 2021-12-31 | NT$679.34 Million | NT$-27.76 Million | -0.041x | -96.97% |
| 2020-12-31 | NT$907.70 Million | NT$-18.83 Million | -0.021x | -118.32% |
| 2019-12-31 | NT$691.64 Million | NT$78.34 Million | 0.113x | -- |